 Over the past 28 years, the Dept. of Defense (DOD) has funded almost $16 billion in medical research through the Congressionally Directed Medical Research Program. For the first time, scleroderma has been designated as focus research area with FY 2020 funding of $5 million, in part due to efforts of the Scleroderma Foundation and Scleroderma Research Foundation. As I have been doing grant reviews for the DOD for the past two years, I was asked to participate in the organizational meeting for the new program area and also asked to do an initial short presentation focused on giving the group a perspective on this rare disease from the viewpoint of someone living with the disease and also involved in patient education and researc
Over the past 28 years, the Dept. of Defense (DOD) has funded almost $16 billion in medical research through the Congressionally Directed Medical Research Program. For the first time, scleroderma has been designated as focus research area with FY 2020 funding of $5 million, in part due to efforts of the Scleroderma Foundation and Scleroderma Research Foundation. As I have been doing grant reviews for the DOD for the past two years, I was asked to participate in the organizational meeting for the new program area and also asked to do an initial short presentation focused on giving the group a perspective on this rare disease from the viewpoint of someone living with the disease and also involved in patient education and researc
Here is a link to a just published summary of that meeting. It includes a summary of my presentation:
https://cdmrp.army.mil/srp/pdf/SRP%20FY20%20StakeHolders%20Summary.pdf
My hope is that this will lead to beneficial research for everyone living with scleroderma in the relatively near future.
The DOD also did a feature story on me: https://cdmrp.army.mil/cwg/stories/2020/ed_harris_profile
Ed Harris
CEO/Founder
Scleroderma Education Project
